Navigation Links
ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
Date:10/20/2008

the newly created position of vice president, clinical and development programs where his primary responsibility is the leadership and co-ordination of development activities within the NDA/MAA/NDS submission team for maribavir, ViroPharma's anti-cytomegalovirus compound. He has 17 years of industry and academic experience in the area of infectious diseases and antimicrobials clinical research. Prior to joining ViroPharma in 2005, Dr. Gelone was the director of the medical science liaison team and led publications strategy for Vicuron Pharmaceuticals. From 2001 to 2002, he was director of clinical pharmacology and discovery medicine in antimicrobial drug discovery for GlaxoSmithKline. Dr. Gelone has held numerous academic appointments at Temple University, including director of clinical research, director of residency and fellowship programs (School of Pharmacy), adjunct associate professor in the division of infectious diseases, senior research fellow and steering committee member for the General Clinical Research Center (School of Medicine). He is currently an associate professor of community medicine and preventive health at Drexel University College of Medicine, and associate professor of pharmacy with tenure at the Temple University School of Pharmacy. Dr. Gelone holds both a Bachelors of Science in Pharmacy and a Doctor of Pharmacy degree from the Temple University School of Pharmacy.

Glenn S. Tillotson, Ph.D., FRSM, FCCP, has joined ViroPharma as head of medical affairs where he will be responsible to lead the medical affairs team providing medical leadership to disease-specific strategy to support optimal positioning of marketed and development products. Prior to joining ViroPharma, Dr. Tillotson was most recently Executive Director of Scientific Affairs at Replidyne. Dr. Tillotson brings to ViroPharma over 20 years pharmaceutical industry experience in numerous areas including clinical research, marketing, scientific communications, strategic develo
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. ViroPharma to Present at Two Upcoming Healthcare Conferences
2. ViroPharma Provides 2008 Outlook
3. ViroPharma to Present at the BIO CEO & Investor Conference
4. ViroPharma to Release 2007 Fourth Quarter and Full Year Financial Results on February 27, 2008
5. ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference
6. ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference
7. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
8. ViroPharma to Present at Two Upcoming Healthcare Conferences
9. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
10. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
11. ViroPharma To Acquire Lev Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... care startups reported $572 million in total investments across ... according to the BioEnterprise Midwest Health ... while the total dollar levels ... companies financed remains the same.   (Logo: ...
... Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company ... for the third quarter ended September 30,2010 on Wednesday, November ... followed by a live webcast and conference call at 5:00 ... the call and webcast to discuss financial results and recent ...
... ... ... ... keyed by longUrl, so we need to grab the first one. for (var r in data.results) { first_result = ...
Cached Biology Technology:Midwest Health Care Startups Raise $572 Million Through Q3 2010 2Midwest Health Care Startups Raise $572 Million Through Q3 2010 3Taking Control of Diabetes: Support World Diabetes Day (14th November 2010) 2Taking Control of Diabetes: Support World Diabetes Day (14th November 2010) 3Taking Control of Diabetes: Support World Diabetes Day (14th November 2010) 4Taking Control of Diabetes: Support World Diabetes Day (14th November 2010) 5Taking Control of Diabetes: Support World Diabetes Day (14th November 2010) 6Taking Control of Diabetes: Support World Diabetes Day (14th November 2010) 7Taking Control of Diabetes: Support World Diabetes Day (14th November 2010) 8
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB ... Good Clinical Practices (GCP) audit to confirm its ... (FDA) regulations. This accomplishment enables HITLAB to conduct ... utilizing the highest principles for patient safety and ... improve global healthcare access, quality, and delivery with ...
(Date:12/17/2014)... 2014 Research and Markets ( ... "Global Chemical Sensor Market 2015-2019" report ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend upcoming ... medical sensors in biomedical applications. Chemical sensors help ... correct diagnosis during surgical procedures. The Global Chemical ...
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... of the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition ... individuals. Facial recognition system measures the overall facial ... edges, mouth, and the distance between eyes. Facial ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3
... one of the millions who dread the spring allergy season, ... May 2009 issue of the Journal of Leukocyte Biology ... scientists have identified a previously unknown cellular switch that turns ... study also suggests that at least for some people with ...
... Researchers have detected common plant toxins that affect human ... results from the new study also suggest that smoldering ... reason to keep human exposures to a minimum during ... as alkaloids -- helps researchers understand how they cycle ...
... A wolverine first photographed by a remote-controlled camera on ... closely related to Rocky Mountain populations, according to a ... Their findings are published in the latest edition of ... of hair collected from the first scientifically verified California ...
Cached Biology News:Just in time for spring: Scientists find the cellular on and off switch for allergies and asthma 2Potentially harmful chemicals found in forest fire smoke 2Origins of wolverine in California genetically verified 2
Goat polyclonal to Ephrin B2 ( Abpromise for all tested applications). entrezGeneID: 1948 SwissProtID: P52799...
...
Rabbit polyclonal to LCAT ( Abpromise for all tested applications). entrezGeneID: 3931 SwissProtID: P04180...
Rabbit polyclonal to ECSIT ( Abpromise for all tested applications). entrezGeneID: 51295 SwissProtID: Q96HQ7...
Biology Products: